| |
| |
|
| Insider
Information: |
Fitzgerald Joseph Michael |
| Relationship: |
EVP & Group Pres, Card... |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
192,867 |
|
|
Indirect Shares
|
4,894 |
|
|
| Direct
Value |
$14,025,288 |
|
|
|
Indirect Value
|
$355,892 |
|
|
| Total
Shares |
197,761 |
|
|
| Total
Value |
$14,381,180 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP & Group Pres, Card... |
2024-02-20 |
192,867 |
2024-02-20 |
4,894 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
230 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 10
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2022-07-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
216,871 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2022-12-13 |
4 |
OE |
$7.39 |
$585,761 |
D/D |
79,264 |
296,135 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2022-12-13 |
4 |
AS |
$47.78 |
$3,787,234 |
D/D |
(79,264) |
216,871 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,134 |
230,005 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-01-01 |
4 |
D |
$46.27 |
$308,066 |
D/D |
(6,658) |
223,347 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
630 |
4,344 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,520 |
220,827 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,000 |
209,827 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-15 |
4/A |
D |
$47.29 |
$107,727 |
D/D |
(2,278) |
212,164 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$117,658 |
D/D |
(2,488) |
211,954 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,615 |
214,442 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-16 |
4 |
D |
$46.48 |
$83,943 |
D/D |
(1,806) |
214,318 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,960 |
216,124 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,166 |
218,484 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-17 |
4 |
D |
$46.54 |
$95,686 |
D/D |
(2,056) |
216,428 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-18 |
4 |
D |
$46.54 |
$85,122 |
D/D |
(1,829) |
218,305 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
220,134 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-21 |
4 |
D |
$46.23 |
$88,900 |
D/D |
(1,923) |
220,277 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,895 |
222,200 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-05-16 |
4 |
AS |
$53.60 |
$3,394,856 |
D/D |
(63,339) |
213,859 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-05-16 |
4 |
OE |
$13.08 |
$744,527 |
D/D |
56,921 |
277,198 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-09-20 |
4 |
AS |
$55.00 |
$872,685 |
D/D |
(15,867) |
197,992 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-12-29 |
4 |
AS |
$57.50 |
$4,711,550 |
D/D |
(81,940) |
174,241 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-12-29 |
4 |
OE |
$16.31 |
$949,063 |
D/D |
58,189 |
256,181 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,799 |
196,040 |
0 |
- |
|
230 Records found
|
|
Page 1 of 10 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
